NCT03657537View on ClinicalTrials.gov

Effects of Ketone Bodies on Cognition in Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

February 14, 2019

Study Completion Date

February 14, 2019

Conditions
Type2 DiabetesKetonemiaCognitive Change
Interventions
DRUG

Ketone infusion

β-hydroxybutyrate is infused intravenously.

DRUG

Saline infusion

saline is infused intravenously.

Trial Locations (1)

Unknown

Department of Research in Endocrinology, Bispebjerg University Hospital, Copenhagen

All Listed Sponsors
collaborator

Psychiatric Centre Rigshospitalet

OTHER

lead

Bispebjerg Hospital

OTHER

NCT03657537 - Effects of Ketone Bodies on Cognition in Type 2 Diabetes | Biotech Hunter | Biotech Hunter